cosmictrials.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /vendor Sitemap: | ||
Meta Tags
| Title | Cosmic-313 Investigating Cabozantinib in Hepatocellular |
| Description | Thank you for your interest in the COSMIC Phase 3 Study of Cabozantinib with Nivolumab and Ipilimumab vs Nivolumab and Ipilimumab Alone in Advanced Treatment-Naive Renal Cell |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 40.71.11.136 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
cosmictrials.com Valuation
|
US$253,775
Last updated: 2023-05-17 09:38:05
cosmictrials.com has Semrush global rank of 41,707,582. cosmictrials.com has an estimated worth of US$ 253,775, based on its estimated Ads revenue. cosmictrials.com receives approximately 29,282 unique visitors each day. Its web server is located in United States, with IP address 40.71.11.136. According to SiteAdvisor, cosmictrials.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$253,775 |
| Daily Ads Revenue | US$235 |
| Monthly Ads Revenue | US$7,028 |
| Yearly Ads Revenue | US$84,332 |
| Daily Unique Visitors | 1,953 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| cosmictrials.com. | A | 600 | IP: 40.71.11.136 |
| cosmictrials.com. | NS | 3600 | NS Record: ns30.domaincontrol.com. |
| cosmictrials.com. | NS | 3600 | NS Record: ns29.domaincontrol.com. |
HtmlToTextCheckTime:2023-05-17 09:38:05
| Cosmic-313 Investigating Cabozantinib in Hepatocellular Cancer --> Cookies are essential for the operation of our website. By using our website, you agree to the use of cookies. This website uses cookies to improve and personalize content, and for tracking and analytics. By clicking "Accept All Cookies", you are providing consent for Exelixis to collect and retain personal data for Exelixis to optimize the use of this website. You can learn more about Exelixis’ use of cookies by reviewing Exelixis’ Privacy Statement . REJECT NONESSENTIAL COOKIES ACCEPT ALL COOKIES CONTACT EXELIXIS Thank you for your interest in the COSMIC Trials. The COSMIC Trials are no longer recruiting Phase 1b study of cabozantinib administered alone or in combination with atezolizumab for solid tumors Learn More at Clinicaltrials.gov Phase 3 pivotal trial of cabozantinib in patients with radioiodine-refractory differentiated thyroid cancer who have progressed after prior VEGFR (vascular endothelial growth |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 0 Content-Type: text/html; charset=UTF-8 Location: https://cosmictrials.com/ Date: Fri, 18 Mar 2022 09:16:37 GMT HTTP/1.1 301 Moved Permanently Content-Length: 152 Content-Type: text/html; charset=utf-8 Date: Fri, 18 Mar 2022 09:16:38 GMT Server: Microsoft-IIS/10.0 Location: https://www.cosmictrials.com/ Set-Cookie: ARRAffinity=c52151406944a2cc6fe1552b9a9921858ee2ccb9175fa0a9873f56c3f57f19dd;Path=/;HttpOnly;Secure;Domain=cosmictrials.com Set-Cookie: ARRAffinitySameSite=c52151406944a2cc6fe1552b9a9921858ee2ccb9175fa0a9873f56c3f57f19dd;Path=/;HttpOnly;SameSite=None;Secure;Domain=cosmictrials.com X-Powered-By: ASP.NET HTTP/1.1 200 OK Content-Length: 94030 Content-Type: text/html Last-Modified: Mon, 14 Mar 2022 19:20:40 GMT Accept-Ranges: bytes ETag: "0f46697d837d81:0" Server: Microsoft-IIS/10.0 Request-Context: appId=cid-v1:e365b6ff-9145-465b-8307-f120eeb3d02a Access-Control-Expose-Headers: Request-Context X-Powered-By: ASP.NET Set-Cookie: ARRAffinity=c52151406944a2cc6fe1552b9a9921858ee2ccb9175fa0a9873f56c3f57f19dd;Path=/;HttpOnly;Secure;Domain=www.cosmictrials.com Set-Cookie: ARRAffinitySameSite=c52151406944a2cc6fe1552b9a9921858ee2ccb9175fa0a9873f56c3f57f19dd;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.cosmictrials.com Date: Fri, 18 Mar 2022 09:16:38 GMT |
cosmictrials.com Whois Information
Domain Name: COSMICTRIALS.COM Registry Domain ID: 2421516823_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-08-04T13:27:14Z Creation Date: 2019-08-09T15:34:30Z Registry Expiry Date: 2022-08-09T15:34:30Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS29.DOMAINCONTROL.COM Name Server: NS30.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-03-18T09:40:15Z <<< |